Check-Cap Ltd (7CC) - Total Liabilities
Based on the latest financial reports, Check-Cap Ltd (7CC) has total liabilities worth €4.05 Million EUR (≈ $4.73 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Check-Cap Ltd - Total Liabilities Trend (2016–2025)
This chart illustrates how Check-Cap Ltd's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Check-Cap Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
Check-Cap Ltd Competitors by Total Liabilities
The table below lists competitors of Check-Cap Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Green Earth Group N.V.
AS:HWK
|
USA | €141.00K |
|
COSCIENS Biopharma Inc.
NASDAQ:CSCI
|
USA | $20.46 Million |
|
Ragnar Metals Ltd
AU:RAG
|
Australia | AU$180.45K |
|
Energy Development Company Limited
NSE:ENERGYDEV
|
India | Rs1.83 Billion |
|
Jupiter Neurosciences, Inc. Common Stock
NASDAQ:JUNS
|
USA | $7.40 Million |
|
Allmed Solutions Ltd
TA:ALMD
|
Israel | ILA3.48 Million |
|
Taranis Resources Inc
V:TRO
|
Canada | CA$1.07 Million |
|
SenesTech Inc
NASDAQ:SNES
|
USA | $3.28 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Check-Cap Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Check-Cap Ltd stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.54 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Check-Cap Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Check-Cap Ltd (2016–2025)
The table below shows the annual total liabilities of Check-Cap Ltd from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €4.05 Million ≈ $4.73 Million |
+121.62% |
| 2024-12-31 | €1.83 Million ≈ $2.14 Million |
+37.37% |
| 2023-12-31 | €1.33 Million ≈ $1.55 Million |
-67.79% |
| 2022-12-31 | €4.13 Million ≈ $4.83 Million |
-16.89% |
| 2021-12-31 | €4.97 Million ≈ $5.81 Million |
+52.39% |
| 2020-12-31 | €3.26 Million ≈ $3.81 Million |
+2.03% |
| 2019-12-31 | €3.19 Million ≈ $3.74 Million |
+32.79% |
| 2018-12-31 | €2.41 Million ≈ $2.81 Million |
+20.24% |
| 2017-12-31 | €2.00 Million ≈ $2.34 Million |
+5.99% |
| 2016-12-31 | €1.89 Million ≈ $2.21 Million |
-- |
About Check-Cap Ltd
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.